1
TÍTULO: Bayesian network analyses of resistance pathways against efavirenz and nevirapine
AUTORES: Koen Deforche; Ricardo J Camacho; Zehave Grossman; Marcelo A Soares; Kristel Van Laethem; David A Katzenstein; Richard R Harrigan; Rami Kantor; Robert Shafer; Anne Mieke Vandamme ;
PUBLICAÇÃO: 2008, FONTE: AIDS, VOLUME: 22, NÚMERO: 16
INDEXADO EM: Scopus WOS CrossRef
2
TÍTULO: Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting
AUTORES: Miller, V; Vandamme, AM ; Loveday, C; Staszewski, S; Lundgren, J; Youle, M; Ait Khaled, M; Boucher, C; Brun Vezinet, F; Dedes, N; Giaquinto, C; Hertogs, K; Houyez, F; Perrin, L; Pillay, D; Schmit, JC; Schuurman, R; Lange, J; Banhegyi, D; Biondi, G; Broekhuizen, A; Bush Donovan, C; Camacho, R; Carlier, H; Clavel, F; Clotet, B; Clumeck, N; Colebunders, R; De Clerq, K; De Jaegher, JJ; De Schrijver, G; De Smet, K; Hall, W; Harrigan, R; Hatzakis, A; Hellmann, N; Hoetelmans, R; Holtzer, C; Katlama, C; Larder, D; Loriaux, E; McCreedy, B; Mulcahy, F; Opravil, M; Phillips, A; Ruiz, N; Shulse, E; Sonnerborg, A; Soriano, V; Steel, H; Vella, S; Williams, A; ...Mais
PUBLICAÇÃO: 2001, FONTE: AIDS, VOLUME: 15, NÚMERO: 3
INDEXADO EM: Scopus WOS CrossRef: 120
3
TÍTULO: Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-up
AUTORES: Vandamme, AM; Houyez, F; Banhegyi, D; Clotet, B; De Schrijver, G; De Smet, KAL; Hall, WW; Harrigan, R; Hellmann, N; Hertogs, K; Holtzer, C; Larder, B; Pillay, D; Race, E; Schmit, JC; Schuurman, R; Shulse, E; Sonnerborg, A; Miller, V;
PUBLICAÇÃO: 2001, FONTE: ANTIVIRAL THERAPY, VOLUME: 6, NÚMERO: 1
INDEXADO EM: Scopus WOS